LYRA earnings: a positive outcome, +9.1%

On April 30, 2024, Lyra Therapeutics, Inc. reached its earnings. The result was a positive outcome, and the stock moved +9.1% in the window around the event. It had already run -24.1% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.